ARCHIVES

“Treatment INDs” Seen As Major Threat To Clinical Trials

This article is from The Cancer Letter archive.

Vol. 13 No. 34 | August 21, 1987

Download PDF Visit The Full Archive

Related Articles

Congress Insists On No Downward Negotiations; NCI May Drop 2000 To 300 Grants In FY 1991

November 9, 1990

Zometa Better Than Placebo In Treatment Of Bone Mets

August 31, 2001

Melanoma Cancer Vaccine Tested By Cooperative Group

August 29, 2003

Blincyto Demonstrates Response In Minimal Residual Disease ALL

December 26, 2014

Study Identifies Women Likely To Benefit From Therapy With Aromatase Inhibitors

November 24, 2006

ASCO Releases Three Guidelines For Cancer Survivorship Care

April 25, 2014